Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial

Andre, T; Amonkar, M; Norquist, JM; Shiu, KK; Kim, TW; Jensen, BV; Jensen, LH; Punt, CJA; Smith, D; Garcia-Carbonero, R; Sevilla, I; de la Fouchardiere, C; Rivera, F; Elez, E; Diaz, LA; Yoshino, T; Van utsem, E; Yang, P; Farooqui, M; Le, DT – 2021